Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy.

Saved in:
Bibliographic Details
Title: Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy.
Authors: Zakaria NH; Department of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt., Hashad D; Department of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt., Saied MH; Department of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt., Hegazy N; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt., Elkayal A; Department of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt., Tayae E; Department of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt. Eman.Tayae@alexmed.edu.eg.
Source: Human genomics [Hum Genomics] 2023 May 18; Vol. 17 (1), pp. 43. Date of Electronic Publication: 2023 May 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364 (Electronic) Linking ISSN: 14739542 NLM ISO Abbreviation: Hum Genomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1479-7364
DOI:10.1186/s40246-023-00493-5